Cargando…

ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus

The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thangaratinam, Shakila, Cooray, Shamil D, Sukumar, Nithya, Huda, Mohammed S B, Devlieger, Roland, Benhalima, Katrien, McAuliffe, Fionnuala, Saravanan, Ponnusamy, Teede, Helena J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Practice Guidance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/ https://www.ncbi.nlm.nih.gov/pubmed/32454456 http://dx.doi.org/10.1530/EJE-20-0401

Ejemplares similares

Endocrinology in the time of COVID-19: Management of pituitary tumours
por: Fleseriu, Maria, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
por: Newell-Price, John, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism
por: Boelaert, Kristien, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
por: Arlt, Wiebke, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
por: Vrachimis, Alexis, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis
por: Gittoes, Neil J, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation
por: Wake, Deborah J, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2021)

Protocol for development and validation of a clinical prediction model for adverse pregnancy outcomes in women with gestational diabetes
por: Cooray, Shamil D., et al.
Publicado: (2020)

SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus
por: Baldeweg, S E, et al.
Publicado: (2018)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients
por: Walsh, Jennifer, et al.
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypocalcaemia in adult patients
por: Turner, Jeremy, et al.
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients
por: Baldeweg, Stephanie E, et al.
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
por: Higham, C E, et al.
Publicado: (2018)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of severe symptomatic hyponatraemia in adult patients
por: Ball, Stephen, et al.
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients
por: Arlt, Wiebke
Publicado: (2016)

Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in women with gestational diabetes: The PeRSonal GDM model
por: Cooray, Shamil D., et al.
Publicado: (2022)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
por: Fontana, Robert J., et al.
Publicado: (2023)

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health
por: Hardy, Anthony, et al.
Publicado: (2018)

Update: use of the benchmark dose approach in risk assessment
por: Hardy, Anthony, et al.
Publicado: (2017)

Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles
por: More, Simon, et al.
Publicado: (2021)

Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health
por: More, Simon, et al.
Publicado: (2021)

Glucose Homeostasis, Fetal Growth and Gestational Diabetes Mellitus in Pregnancy after Bariatric Surgery: A Scoping Review
por: Deleus, Ellen, et al.
Publicado: (2020)

Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals
por: More, Simon John, et al.
Publicado: (2019)

Screening and Management of Gestational Diabetes Mellitus after Bariatric Surgery
por: Benhalima, Katrien, et al.
Publicado: (2018)

Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
por: Benhalima, Katrien, et al.
Publicado: (2016)

UK’s initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals
por: Chilcott, Robert P, et al.
Publicado: (2019)

Guidance on dermal absorption
por: Buist, Harrie, et al.
Publicado: (2017)

Reporting data on pesticide residues in food and feed according to Regulation (EC) No 396/2005 (2016 data collection)
por: Brancato, Alba, et al.
Publicado: (2017)

Guidance on the identity, characterisation and conditions of use of feed additives
por: Rychen, Guido, et al.
Publicado: (2017)

Guidance on quantitative pest risk assessment
por: Jeger, Michael, et al.
Publicado: (2018)

Update: methodological principles and scientific methods to be taken into account when establishing Reference Points for Action (RPAs) for non‐allowed pharmacologically active substances present in food of animal origin
por: Knutsen, Helle Katrine, et al.
Publicado: (2018)

Guidance on the assessment of the safety of feed additives for the consumer
por: Rychen, Guido, et al.
Publicado: (2017)

Guidance on the assessment of the efficacy of feed additives
por: Rychen, Guido, et al.
Publicado: (2018)

Guidance on the assessment criteria for applications for new or modified stunning methods regarding animal protection at the time of killing
por: More, Simon, et al.
Publicado: (2018)

Guidance on the assessment of the safety of feed additives for the target species
por: Rychen, Guido, et al.
Publicado: (2017)

Reporting data on pesticide residues in food and feed according to Regulation (EC) No 396/2005 (2017 data collection)
por: Brancato, Alba, et al.
Publicado: (2018)

Guidance on the characterisation of microorganisms used as feed additives or as production organisms
por: Rychen, Guido, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jdg0lpjpf44g4k5h9vfpkf1iau